.Competing passions.R.S., M.S., H.G. and A.A.R. are actually planners of the 1M1M campaign.
H.G. and A.A.R. are board of directors participants and R.S., M.S.
and A.A.R. are actually members of the medical advisory committee of N1C. A.A.R.
discloses work by LUMC, which possesses patents on exon-skipping technology, some of which has actually been actually licensed to BioMarin as well as consequently sublicensed to Sarepta. As co-inventor of a number of these patents, A.A.R. was actually allowed to an allotment of aristocracies.
A.A.R. additionally makes known acting as professional for PTC Therapeutics, Sarepta Rehabs, Regenxbio, Dyne Therapies, Lilly, BioMarin Pharmaceuticals Inc., Eisai, Entrada, Takeda, Splicesense, Galapagos, Sapreme, Italfarmaco and Astra Zeneca. In the past 5 years, A.A.R.
additionally carried out impromptu getting in touch with for Alpha Anomeric. A.A.R. additionally reports membership of the clinical boards of advisers of Eisai, Hybridize Therapies, Silence Therapies, Sarepta Rehabs, Sapreme and also Mitorx.
Before 5 years, A.A.R. was actually likewise a clinical advisory board member for ProQR. Wage for A.A.R.
u00e2 s consulting and also advising tasks is paid to LUMC. In the past 5 years, LUMC additionally got sound speaker honoraria from PTC Therapies, Alnylam Netherlands, Italfarmaco and also Pfizer as well as funding for agreement analysis from Sapreme, Eisai, Galapagos, Synaffix as well as Alpha Anomeric. Task funding is actually received from Sarepta Rehabs and Entrada using unregulated gives.
H.G. has absolutely nothing to disclose in regard to the subject matters dealt with in this particular manuscript. In the past 5 years, he has actually additionally received working as a consultant gratuity coming from UCB.
M.S. obtained working as a consultant honoraria coming from Ionis, UCB, Prevail, Orphazyme, Biogen, Servier, Reata, GenOrph, AviadoBio, Biohaven, Zevra, Lilly and Solaxa in the past 5 years, all unassociated to the present composition. R.S.
has absolutely nothing to divulge in regard to the subjects covered in this particular document. She has actually gotten speaker and/or consultancy gratuity or even funding payments from Abbvie, Bial, STADA and Everpharma previously 5 years.